174 related articles for article (PubMed ID: 20346888)
1. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
Klemencic S
Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
Lim AY; Gaffney K; Scott DG
Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
[TBL] [Abstract][Full Text] [Related]
3. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
Hocaoglu N; Atilla R; Onen F; Tuncok Y
Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
[TBL] [Abstract][Full Text] [Related]
4. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
6. Cotton wool spots associated with interferon beta-1 alpha therapy.
Longmuir R; Lee AG; Rouleau J
Semin Ophthalmol; 2007; 22(1):49-53. PubMed ID: 17366120
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide-associated pancytopenia with or without methotrexate.
Chan J; Sanders DC; Du L; Pillans PI
Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-induced pancytopenia: a case series of 46 patients.
Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
[TBL] [Abstract][Full Text] [Related]
9. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
10. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Basin KS; Escalante A; Beardmore TD
J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
[TBL] [Abstract][Full Text] [Related]
11. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
[TBL] [Abstract][Full Text] [Related]
12. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
13. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths).
Berthelot JM; Maugars Y; Hamidou M; Chiffoleau A; Barrier J; Grolleau JY; Prost A
Rev Rhum Engl Ed; 1995; 62(7-8):477-86. PubMed ID: 8574610
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N
Sante; 2006; 16(3):167-72. PubMed ID: 17284392
[TBL] [Abstract][Full Text] [Related]
15. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
Nakazaki S; Murayama T; Katoh S
Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
[TBL] [Abstract][Full Text] [Related]
16. Adverse events in methotrexate-treated rheumatoid arthritis patients.
Sandoval DM; Alarcón GS; Morgan SL
Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
[TBL] [Abstract][Full Text] [Related]
17. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Calvo-Romero JM
Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
[TBL] [Abstract][Full Text] [Related]
18. Visual field changes in methotrexate therapy. Case report and review of the literature.
Sbeity ZH; Baydoun L; Schmidt S; Loeffler KU
J Med Liban; 2006; 54(3):164-7. PubMed ID: 17190135
[TBL] [Abstract][Full Text] [Related]
19. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
[TBL] [Abstract][Full Text] [Related]
20. Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.
Yang CP; Kuo MC; Guh JY; Chen HC
Ren Fail; 2006; 28(1):95-7. PubMed ID: 16526326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
